KYTX EPS Estimates
Kyverna Therapeutics, Inc.
$5.90
+$0.21(+3.69%)
30
Overall
60
Value
10
Tech
21
Quality
Market Cap
$351.58M
Volume
184.65K
52W Range
$5.96 - $13.67
Target Price
$30.40
KYTX EPS estimates: the consensus estimate for Kyverna Therapeutics, Inc.'s current fiscal year is -$2.70 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KYTX EPS Estimates
- EPS estimate, current quarter
- $-0.68
- EPS estimate, next quarter
- $-0.73
- EPS estimate, current year
- $-2.70
- EPS estimate, next year
- $-2.95
- EPS growth, 3-year
- +61.43%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.64 |
| 2024 | $-3.33 |
| 2023 | $-89.61 |
| 2022 | $-63.43 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $5.90 | +3.7% | 184.65K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW